These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 12384530

  • 1. Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.
    Huang SF, Kim SJ, Lee AT, Karashima T, Bucana C, Kedar D, Sweeney P, Mian B, Fan D, Shepherd D, Fidler IJ, Dinney CP, Killion JJ.
    Cancer Res; 2002 Oct 15; 62(20):5720-6. PubMed ID: 12384530
    [Abstract] [Full Text] [Related]

  • 2. Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel.
    Tedjarati S, Baker CH, Apte S, Huang S, Wolf JK, Killion JJ, Fidler IJ.
    Clin Cancer Res; 2002 Jul 15; 8(7):2413-22. PubMed ID: 12114447
    [Abstract] [Full Text] [Related]

  • 3. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 15; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 4. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep 15; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.
    Karashima T, Sweeney P, Slaton JW, Kim SJ, Kedar D, Izawa JI, Fan Z, Pettaway C, Hicklin DJ, Shuin T, Dinney CP.
    Clin Cancer Res; 2002 May 15; 8(5):1253-64. PubMed ID: 12006546
    [Abstract] [Full Text] [Related]

  • 6. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 model.
    Muramaki M, Miyake H, Hara I, Kamidono S.
    Int J Oncol; 2005 Mar 15; 26(3):623-8. PubMed ID: 15703816
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha.
    Miyake K, Tsuchida K, Sugino H, Imura S, Morine Y, Fujii M, Shimada M.
    Cancer Chemother Pharmacol; 2007 Jan 15; 59(1):113-26. PubMed ID: 16699793
    [Abstract] [Full Text] [Related]

  • 8. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP, Sharma G, Dhanalakshmi S, Agarwal C, Agarwal R.
    Cancer Epidemiol Biomarkers Prev; 2003 Sep 15; 12(9):933-9. PubMed ID: 14504208
    [Abstract] [Full Text] [Related]

  • 9. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.
    Sweeney CJ, Miller KD, Sissons SE, Nozaki S, Heilman DK, Shen J, Sledge GW.
    Cancer Res; 2001 Apr 15; 61(8):3369-72. PubMed ID: 11309294
    [Abstract] [Full Text] [Related]

  • 10. A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.
    Sasaki H, Klotz LH, Sugar LM, Kiss A, Venkateswaran V.
    Biochem Biophys Res Commun; 2015 Aug 28; 464(3):848-54. PubMed ID: 26182875
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 28; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
    Inoue K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ, McConkey DJ, Sweeney P, Radinsky R, Dinney CP.
    Clin Cancer Res; 2000 Dec 28; 6(12):4874-84. PubMed ID: 11156247
    [Abstract] [Full Text] [Related]

  • 13. [Observation of the antitumor effect of endostar combined with docetaxel under different administration sequences].
    Yuan J, Wu CW, Liu ZJ, Wei XY, Li K.
    Zhonghua Zhong Liu Za Zhi; 2010 Aug 28; 32(8):580-5. PubMed ID: 21122408
    [Abstract] [Full Text] [Related]

  • 14. Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.
    Slaton JW, Perrotte P, Inoue K, Dinney CP, Fidler IJ.
    Clin Cancer Res; 1999 Oct 28; 5(10):2726-34. PubMed ID: 10537335
    [Abstract] [Full Text] [Related]

  • 15. Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma.
    Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T.
    Clin Cancer Res; 2003 Feb 28; 9(2):886-99. PubMed ID: 12576464
    [Abstract] [Full Text] [Related]

  • 16. High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer.
    Fizazi K, Sikes CR, Kim J, Yang J, Martinez LA, Olive MC, Logothetis CJ, Navone NM.
    Anticancer Res; 2004 Feb 28; 24(5A):2897-903. PubMed ID: 15517894
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.
    Kim SJ, Uehara H, Yazici S, Langley RR, He J, Tsan R, Fan D, Killion JJ, Fidler IJ.
    Cancer Res; 2004 Jun 15; 64(12):4201-8. PubMed ID: 15205332
    [Abstract] [Full Text] [Related]

  • 18. IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis.
    Bauer JA, Morrison BH, Grane RW, Jacobs BS, Borden EC, Lindner DJ.
    J Interferon Cytokine Res; 2003 Jan 15; 23(1):3-10. PubMed ID: 12639293
    [Abstract] [Full Text] [Related]

  • 19. Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.
    Adam L, Black PC, Kassouf W, Eve B, McConkey D, Munsell MF, Benedict WF, Dinney CP.
    J Urol; 2007 May 15; 177(5):1900-6. PubMed ID: 17437845
    [Abstract] [Full Text] [Related]

  • 20. Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma.
    Arakawa Y, Shimada M, Utsunomiya T, Imura S, Morine Y, Ikemoto T.
    J Surg Res; 2012 Jan 15; 172(1):95-101. PubMed ID: 20851413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.